This page has been archived.
Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.
Department
Assisted Human Reproduction Agency of
Canada
Canadian Institutes of Health Research
Hazardous Materials Information Review
Commission
Patented Medicine Prices Review Board
Public Health Agency of Canada
Ministry Summary
Vote | (thousands of dollars) | 2008-2009 | 2007-2008 | Difference |
Main Estimates | Main Estimates | |||
|
|
|
|
|
Health | ||||
Department | ||||
1 | Operating expenditures | 1,661,621 | 1,690,951 | (29,329) |
5 | Capital expenditures | 60,000 | . . . . . | 60,000 |
10 | Grants and contributions | 1,358,089 | 1,225,859 | 132,229 |
(S) | Contributions to employee benefit plans | 110,949 | 111,378 | (429) |
(S) | Minister of Health - Salary and motor car allowance | 76 | 75 | 2 |
|
|
|||
Total Department | 3,190,735 | 3,028,263 | 162,472 | |
|
|
|
|
|
Assisted Human Reproduction Agency of Canada | ||||
15 | Program expenditures | 11,783 | 12,834 | (1,051) |
(S) | Contributions to employee benefit plans | 635 | 642 | (7) |
|
|
|||
Total Agency | 12,418 | 13,476 | (1,058) | |
|
|
|
|
|
Canadian Institutes of Health Research | ||||
20 | Operating expenditures | 42,891 | 42,439 | 452 |
25 | Grants | 881,250 | 822,476 | 58,774 |
(S) | Contributions to employee benefit plans | 4,428 | 4,606 | (178) |
|
|
|||
Total Agency | 928,569 | 869,521 | 59,048 | |
|
|
|
|
|
Hazardous Materials Information Review | ||||
Commission | ||||
30 | Program expenditures | 3,097 | 3,024 | 73 |
(S) | Contributions to employee benefit plans | 468 | 482 | (14) |
|
|
|||
Total Agency | 3,565 | 3,506 | 59 | |
|
|
|
|
|
Patented Medicine Prices Review Board | ||||
35 | Program expenditures | 5,211 | 10,584 | (5,373) |
(S) | Contributions to employee benefit plans | 631 | 891 | (260) |
|
|
|||
Total Agency | 5,842 | 11,475 | (5,633) | |
|
|
|
|
|
Public Health Agency of Canada | ||||
40 | Operating expenditures | 360,479 | 438,390 | (77,911) |
45 | Grants and contributions | 199,617 | 189,271 | 10,346 |
(S) | Contributions to employee benefit plans | 30,434 | 30,681 | (247) |
|
|
|||
Total Agency | 590,530 | 658,342 | (67,812) | |
|
|
|
|
|
Note: Details in the “Ministry Summary” and “Program by Activities” tables may not add to totals due to rounding. |
Strategic Outcome
Accessible and sustainable health system responsive to the health needs of Canadians.
Program Activity
Descriptions
Canadian Health System
This program activity provides strategic policy advice on health care issues such as improved access, quality and integration of health care services to better meet the health needs of Canadians wherever they live or whatever their financial circumstances. The objective is pursued mindful of long-term equity, sustainability and affordability considerations and in close collaboration with provinces and territories, health professionals, administrators, other key stakeholders and citizens. Improved access, quality and integration of health services administration is achieved through investments in the health system and in health system renewal, for instance by reducing wait times for essential services, by working with provinces and territories to ensure that the principles of the Canada Health Act are respected, by developing health information and health measures for Canadians, by meeting the health and health access needs of specific groups such as women and official language minority communities, and by ensuring the implementation of agreements between federal/provincial/territorial Ministers of Health.
Canadian Assisted Human Reproduction
This program activity implements the Assisted Human Reproduction (AHR) Act , whose objective is to protect and promote human health, safety, dignity and human rights in the use of AHR technologies. It develops policies and regulations in the area of assisted human reproduction. The science of AHR evolves rapidly and, as a result, the program activity engages stakeholders on an ongoing basis to find a balance between the needs of patients who use these technologies to help them build their families, the children born from these technologies and the providers of these services with health and safety as the overriding factors. The goal of the policies and regulations is developing a responsive regulatory regime which is a leader both domestically and in the international AHR community, and reflects the objectives put forward in the AHR Act. The program activity gathers input from stakeholders, including the provinces, to ensure a pan-Canadian approach.
International Health Affairs
Health Canada works internationally through leadership, partnerships and collaboration to fulfill its federal mandate of striving to make Canada's population among the healthiest in the world. International Affairs serves as the department's focal point to initiate, coordinate, and monitor departmental policies, strategies and activities that help promote Canadian priorities and values on the international health agenda. International collaboration on global health issues is important given that the health of Canadians is influenced significantly by public health risks originating from other countries. Global issues such as pandemic influenza preparedness, HIV/AIDS strategies and global health security are critical initiatives that are discussed with key external health partners such as the World Health Organization (WHO) and the Pan American Health Organization (PAHO).
Countries and international organizations want to
connect quickly to information about Canada's health care system
and initiatives. The international affairs program activity
strives to share Canada's best policies and practices with other
countries, and assists in the development of bilateral agreements
with numerous countries on important health issues. This program
activity delivers strategic policy advice on international health
issues to the Minister of Health, senior management and the
Health Portfolio, including appropriate representation at
international fora concerning the health portfolio. It also
manages grants to non-profit organizations for projects in the
domain of international health that are aligned with Canada's
priorities in global health.
Strategic Outcome
Access to safe and effective health products and food and information for healthy choices.
Program Activity
Descriptions
Health Products
The Health Products program activity is responsible for a broad range of health protection and promotion activities that affect the everyday lives of Canadians. As the federal authority responsible for the regulation of health products, the program activity evaluates and monitors the safety, quality and effectiveness of drugs (human and animal), biologics, medical devices, and natural health products, under the authority of the Food and Drugs Act and Regulations, as well as the Department of Health Act. The program activity also provides timely, evidence-based and authoritative information to key stakeholders (including but not limited to: health care professionals such as physicians, pharmacists and practitioners such as herbalists, naturopathic doctors, Traditional Chinese Medicine (TCM) practitioners) and members of the public to enable them to make informed decisions and healthy choices.
Food and Nutrition
The Food and Nutrition program activity establishes policies, regulations and standards related to the safety and nutritional quality of food. Food safety standards-quality are enforced by the Canadian Food Inspection Agency (CFIA). The legislative framework for food is found in the Food and Drugs Act and Regulations, the Canadian Food Inspection Agency Act and the Department of Health Act. The program activity also promotes the nutritional health and well-being of Canadians by collaboratively defining, promoting and implementing evidence-based nutrition policies and standards. As the focal point and authoritative source for nutrition and healthy eating policy and promotion, the program activity disseminates timely, evidence-based and authoritative information to Canadians and stakeholders to enable them to make informed decisions and healthy choices.
Strategic Outcome
Reduced Health and Environmental Risks from
Products and Substances, and Healthy, Sustainable Living and
Working Environments.
Program Activity
Descriptions
Sustainable Environmental Health
The environment continues to be a key determinant of health for all Canadians. This program activity promotes and protects the health of Canadians by identifying, assessing and managing health risks posed by environmental factors in living, working and recreational environments. The scope of activities includes: research on drinking water quality, air quality, contaminated sites, toxicology and climate change; clean air programming and regulatory activities; risk assessment and management of: chemical substances, environmental noise, environmental electromagnetic frequencies, products of biotechnology and products of other new and emerging technologies (including nanotechnology); solar ultraviolet radiation; preparedness for nuclear and environmental disasters as well as working with the passenger conveyance industry to protect the travelling public.
Under the Chemical Management Plan, Health Canada
assesses and regulates chemicals used in industrial and consumer
products. Other activities include: implementing a national
bio-monitoring system; developing risk management performance
agreements with industry sectors; and, strengthening the
assessment and management of risks to human health posed by
pharmaceuticals, personal care and consumer products, cosmetics
and food. Finally, enhanced communications and outreach
activities allow Canadians to make better informed decisions
about limiting their exposure to potential environmental hazards.
Relevant Act includes the
Canadian Environmental Protection
Act.
Consumer Products
Health Canada identifies, assesses, manages and
communicates to Canadians the health and safety risks associated
with consumer products (including domestic, industrial and
clinical use products), cosmetics and radiation emitting devices.
This is achieved through research, risk assessments and the
development of risk management strategies to minimize the
exposure of Canadians to potentially hazardous products. Also
included are regulatory monitoring and compliance activities as
well as information, education and guidance aimed at both
industry and the public. Relevant acts include: consumer products
(
Hazardous Products Act)
, cosmetics (
Food and
Drugs Act)
and radiation emitting devices (
Radiation
Emitting Devices Act).
Workplace Health
This program activity provides services to protect the health and safety of the federal public sector, visiting dignitaries, and others. Specific programs include: the provision of occupational health services to federal employees; delivery of the Employee Assistance Program; emergency health services to Internationally Protected Persons; dosimetry services (the measurement of personal, occupational exposure to radiation through the reading of “dosimeters” or plaques enclosed in special holders worn by the user for specified periods); and, Workplace Hazardous Materials Information System (WHMIS) a national hazard communication standard, including worker education, inspector training, and standards for cautionary labels.
Substance Use and Abuse
Through regulatory, programming and educational activities, Health Canada seeks to improve health outcomes by reducing and preventing tobacco consumption and combatting alcohol and drug abuse. Through the Tobacco Act and its regulations, Health Canada regulates aspects of the manufacture and sale of tobacco. It also leads the Federal Tobacco Control Strategy -the goals of which are to: further reduce the prevalence of smoking; decrease the number of cigarettes sold; increase compliance with sales-to-youth laws; reduce exposure to second hand smoke; and, continue to explore ways to regulate the product.
Health Canada administers the Controlled Drugs and Substances Act (CDSA) and its regulations. Through four regional labs, Health Canada provides expert scientific advice and drug analysis services to law enforcement agencies. The Marihuana Medical Access Regulations and related programs control the authorization for use and cultivation of marihuana by those suffering from grave and debilitating illnesses. Health Canada is a partner in the government's anti-drug strategy which includes: prevention programming aimed at youth; facilitating access to treatment programs; compliance and enforcement activities related to controlled substances and precursor chemicals; and, increased resources to Drug Analysis Services commensurate with the increase in law enforcement resources.
Pesticide Regulation
To help prevent unacceptable risks to people and
the environment, and facilitate access to sustainable pest
management tools, Health Canada, through the Pest Management
Regulatory Agency, regulates the importation, sale and use of
pesticides under the federal authority of the
Pest Control
Products Act
(PCPA) and Regulations.
Strategic Outcome
Better health outcomes and reduction of health inequalities between First Nations and Inuit and other Canadians.
Program Activity
Descriptions
First Nations and Inuit Health Programming and Services
The provision of health programs and services by Health Canada to First Nations and Inuit is rooted in the Federal Indian Health Policy. The Department provides health programs and services to First Nations and Inuit as a matter of policy, using the Annual Appropriations Act to obtain Parliamentary approval. Together with First Nations and Inuit and other health partners, the First Nations and Inuit Health Branch through it's regional offices, delivers public health and community health programs on-reserve, these include environmental health and communicable and non-communicable disease prevention, and provision of primary health care services through nursing stations and community health centres in remote and/or isolated communities to supplement and support the services that provincial, territorial and regional health authorities provide. We also support targeted health promotion programs for Aboriginal people, regardless of residency (e.g. Aboriginal Diabetes Initiative) as well as counselling, addictions and mental wellness services. The Non-Insured Health Benefits coverage of drug, dental care, vision care, medical supplies and equipment, short-term crisis intervention mental health services, and medical transportation is available to all registered Indians and recognized Inuit in Canada, regardless of residency.
Program by Activities | |||||||
|
|
|
|
|
|
|
|
(thousands of dollars) | 2008-2009 Main Estimates | 2007-2008 | |||||
|
|
|
|
|
|||
Budgetary | Total | Main | |||||
|
|
|
|
|
|||
Operating | Capital | Grants | Contributions | Less: | Estimates | ||
and other | Revenues | ||||||
transfer | credited | ||||||
payments | to the vote | ||||||
|
|
|
|
|
|
|
|
First Nations and Inuit Health Programming | |||||||
and Services | 1,115,617 | 18,165 | 30,000 | 997,301 | 5,450 | 2,155,633 | . . . . . |
Canadian Health System | 47,034 | 820 | 182,446 | 75,896 | . . . . . | 306,196 | . . . . . |
Health Products | 198,000 | 15,235 | 5,900 | 4,000 | 39,863 | 183,272 | . . . . . |
Sustainable Environmental Health | 156,111 | 10,740 | 605 | . . . . . | 1,400 | 166,056 | . . . . . |
Substance Use and Abuse | 87,944 | 4,733 | 4,250 | 55,816 | . . . . . | 152,743 | . . . . . |
Food and Nutrition | 71,884 | 7,105 | . . . . . | . . . . . | 1,343 | 77,646 | . . . . . |
Pesticide Regulation | 65,626 | 1,645 | . . . . . | . . . . . | 6,975 | 60,296 | . . . . . |
Workplace Health | 47,431 | 877 | . . . . . | . . . . . | 14,140 | 34,168 | . . . . . |
International Health Affairs | 26,716 | . . . . . | 1,875 | . . . . . | . . . . . | 28,591 | . . . . . |
Consumer Products | 23,875 | 680 | . . . . . | . . . . . | 454 | 24,101 | . . . . . |
Canadian Assisted Human Reproduction | 2,033 | . . . . . | . . . . . | . . . . . | . . . . . | 2,033 | . . . . . |
First Nations and Inuit Health | . . . . . | . . . . . | . . . . . | . . . . . | . . . . . | . . . . . | 2,123,076 |
Healthy Environments and Consumer | |||||||
Safety | . . . . . | . . . . . | . . . . . | . . . . . | . . . . . | . . . . . | 333,487 |
Health Policy, Planning and Information | . . . . . | . . . . . | . . . . . | . . . . . | . . . . . | . . . . . | 263,685 |
Health Products and Food | . . . . . | . . . . . | . . . . . | . . . . . | . . . . . | . . . . . | 257,164 |
Pest Control Product Regulation | . . . . . | . . . . . | . . . . . | . . . . . | . . . . . | . . . . . | 50,852 |
|
|
|
|
|
|
|
|
1,842,271 | 60,000 | 225,076 | 1,133,013 | 69,625 | 3,190,735 | 3,028,263 | |
|
|
|
|
|
|
|
|
(dollars) | 2008-2009 | 2007-2008 |
Main Estimates | Main Estimates | |
|
|
|
Grants | ||
Grant to the Canadian Institute for Health Information | 81,746,000 | 24,720,000 |
Grant to the Canadian Partnership Against Cancer | 58,200,000 | 50,000,000 |
Grant to the Canadian Agency for Drugs and Technologies in Health | 16,903,967 | 17,403,967 |
Nunavut Medical Travel Fund | 10,200,000 | 10,200,000 |
Grant to the Health Council of Canada | 10,000,000 | 10,000,000 |
Grant to the Canadian Patient Safety Institute | 8,000,000 | 8,000,000 |
Grant to support the Mental Health Commission of Canada | 7,500,000 | . . . . . |
Grant to the Government of Yukon for the Territorial Health Access | ||
Fund and Operational Secretariat | 6,333,333 | 6,333,334 |
Grant to the Canadian Blood Services : Blood Safety and Effectiveness | ||
and Research and Development | 5,000,000 | 5,000,000 |
Grant to the Government of Nunavut for the Territorial Health Access | ||
Fund | 4,333,334 | 4,333,333 |
Grant to the Government of Northwest Territories for the Territorial | ||
Health Access Fund | 4,333,333 | 4,333,333 |
Grant to the Canadian Centre on Substance Abuse | 3,750,000 | 3,750,000 |
Northwest Territories Medical Travel Fund | 3,200,000 | 3,200,000 |
Grant to eligible non-profit international organizations in support of | ||
their projects or programs on health | 2,475,000 | 2,135,000 |
Yukon Medical Travel Fund | 1,600,000 | 1,600,000 |
Health Canada Post-Doctoral Fellowship Program | 1,000,000 | 1,000,000 |
Natural Health Products Research Grant | 400,000 | 400,000 |
Health Care Strategies and Policy, Federal/Provincial/Territorial | ||
Partnership Grant Program | 96,033 | 96,033 |
International Commission on Radiological Protection | 5,000 | 5,000 |
|
|
|
Total grants | 225,076,000 | 152,510,000 |
|
|
|
Contributions | ||
Contributions for First Nations and Inuit Community Programs | 236,502,522 | 219,913,539 |
First Nations and Inuit Health Services Transfer | 233,853,383 | . . . . . |
Contributions for First Nations and Inuit Health Governance and | ||
Infrastructure Support | 191,527,870 | 185,313,328 |
Contributions for First Nations and Inuit Health Benefits | 135,444,527 | 131,862,740 |
Contributions for First Nations and Inuit Primary Health Care | 122,152,934 | 121,197,000 |
Health Care Strategies and Policy Contribution Program | 50,046,000 | 37,356,240 |
Contributions for First Nations and Inuit Health Facilities and Capital | ||
Program | 46,512,678 | 51,275,042 |
Drug Treatment Funding Program | 26,752,109 | . . . . . |
Contributions Program to improve access to health services for official | ||
language minority communities | 23,000,000 | 23,000,000 |
Contributions in support of the Federal Tobacco Control Strategy | 15,759,000 | 15,759,000 |
Drug Strategy Community Initiatives Fund | 13,304,891 | 11,832,588 |
Contributions for First Nations and Inuit Health Protection | 10,285,281 | 12,169,441 |
Contributions for Bigstone Non-Insured Health Benefits Pilot Project | 8,821,805 | 8,487,200 |
Contributions for the Indian Residential Schools Resolution Health | ||
Support Program | 7,200,000 | . . . . . |
Contribution to the Organization for the Advancement of Aboriginal | ||
People's Health | 5,000,000 | 5,000,000 |
Contribution to strengthen Canada's organs and tissues donation and | ||
transplantation system | 3,600,000 | 3,600,000 |
Women's Health Contributions Program | 2,850,000 | 2,850,000 |
Natural Health Products Research Contribution | 400,000 | 400,000 |
|
|
|
Total contributions | 1,133,013,000 | 830,016,118 |
|
|
|
Items not required | ||
Payments to Indian bands, associations or groups for the control and | ||
provision of health services | . . . . . | 227,903,381 |
Payments to provinces and territories to assist in ensuring access for | ||
Canadians to effective alcohol and drug treatment and rehabilitation | ||
programs and services | . . . . . | 13,200,000 |
Contribution to the Canadian Institute for Health Information | . . . . . | 2,230,000 |
|
|
|
Total items not required | . . . . . | 243,333,381 |
|
|
|
Total | 1,358,089,000 | 1,225,859,499 |
|
|
|
Strategic Outcome
Protection and promotion of the health and
safety of Canadians against the risks associated with assisted
human reproduction technologies.
Program Activity Descriptions
Licencing and Enforcement of a Regulatory Framework for Assisted Human Reproduction Technologies
The Assisted Human Reproduction Agency of Canada would achieve this objective by the following means: issuing licences for controlled activities and for facilities used by qualified persons or organizations; assessing applications against licence requirements, including scientific and ethical considerations; conducting periodic inspections of assisted human reproduction clinics, service providers or research to ensure compliance; and enlisting the participation or support of other recognized organizations in the development of other supporting policy instruments, for example, standards, guidelines and accreditation models.
Health Information and Knowledge Management for Assisted Human Reproduction Technologies
The Assisted Human Reproduction Agency of Canada would achieve this objective by the following means: maintaining a personal health information registry to consolidate health reporting information concerning donors, patients and offspring born of assisted human reproduction procedures to allow for a look-back and trace-back mechanism; providing ongoing reports of assisted human reproduction controlled activities, including success rates by assisted human reproduction clinics and results of research, to enable prospective assisted human reproduction users to make informed decisions; and providing public information on assisted human reproduction matters or issues via a public website or in other forms such as brochures.
Program by Activities | |||
|
|
|
|
(thousands of dollars) | 2008-2009 Main Estimates 2007-2008 | ||
|
|||
Budgetary | Total | Main | |
|
|||
Operating | Estimates | ||
|
|
|
|
Licencing and Enforcement of a Regulatory Framework | |||
for Assisted Human Reproduction Technologies | 7,804 | 7,804 | 6,076 |
Health Information and Knowledge Management for | |||
Assisted Human Reproduction Technologies | 4,614 | 4,614 | 7,400 |
|
|
|
|
12,418 | 12,418 | 13,476 | |
|
|
|
|
Strategic Outcome
Canadian health research advances health knowledge and is responsive to current opportunities and priorities.
Program Activity
Descriptions
Open Research
Enabling the conduct of health research in emerging areas of science across all disciplines that are relevant to health. This is achieved through managing and launching competitions, based on internationally accepted standards of scientific excellence and a peer review process, to fund grants open to all areas of health research.
Strategic Priority Research
Enabling the conduct of health research to address strategic health opportunities, threats and challenges to Canadians, identified in consultation with health research partners and aligned with government priorities. This is achieved through managing and launching competitions to fund grants in targeted priority health research areas.
Strategic Outcome
A strong and talented health research community with the capacity to undertake health research.
Program Activity
Descriptions
Researchers and Trainees
Building the capacity of the Canadian health research community by providing the next generation of multidisciplinary health researchers with training and development support, and providing highly-qualified health researchers with sustained support for scientific careers in health research. This is achieved through managing competitions and programs to fund salary and training awards for health researchers and trainees.
Research Resources and Collaboration
Strengthening the health research community's ability to conduct research by supporting research-enabling activities and resources. This includes: supporting large teams of researchers from across disciplines in resolving some of the most complex health problems facing Canadians; engaging in collaborative activities such as networking between researchers; and providing and maintaining state-of-the-art tools to conduct research such as new equipment, databases and other specialized resources. This is achieved through managing and launching competitions and programs to fund grants that give researchers the resources to better undertake their research.
National and International Partnerships
Developing strong national and international partnerships, through CIHR's thirteen Institutes, to advance strategic health research priorities, and leverage funding and expertise for research. These partners include health policy-makers at provincial and federal levels of government, the private sector, and voluntary health organizations from Canada and abroad. This is achieved through funding grants to support Institute activities, and managing competitions to fund partnered research projects and the participation of Canadian scientists in international research collaborations.
Ethical, Legal and Social Issues
Enabling the conduct of research on ethical, legal
and social issues pertaining to health and health research, and
the application of ethical principles to health research. This is
achieved through managing competitions to fund grants for
research on health-related ethical, legal and social issues, and
conducting consultations to enable dialogue and greater public
engagement.
Strategic Outcome
Health research is translated and adopted into practice, programs and policies that offer more effective health services and products, a strengthened health care system, and the improved health of Canadians.
Program Activity
Descriptions
Knowledge Translation of Health Research
Enabling the effective dissemination and exchange of health research knowledge, and the application of health research results discoveries to lead to improvements in the Canadian health system and overall health of Canadians. This is achieved through managing competitions and programs to fund grants for translating health research discoveries into new or more effective health policy or practice, and for building increased knowledge translation capacity in Canada's health research community.
Commercialization of Health Research
Encouraging innovation and facilitating the commercialization of health research in Canada into new health products and services. This is achieved through managing competitions to fund grants for supporting the commercialization of health research, in partnership with the private sector, and for building increased commercialization capacity in Canada's health research community.
Program by Activities | ||||
|
|
|
|
|
(thousands of dollars) | 2008-2009 Main Estimates | 2007-2008 | ||
|
|
|||
Budgetary | Total | Main | ||
|
|
|||
Operating | Grants | Estimates | ||
|
|
|
|
|
Open Research | 23,132 | 439,500 | 462,632 | . . . . . |
Researchers and Trainees | 10,278 | 185,817 | 196,095 | 203,589 |
Strategic Priority Research | 6,236 | 116,371 | 122,607 | . . . . . |
Research Resources and Collaboration | 2,535 | 48,315 | 50,850 | 69,959 |
Knowledge Translation of Health Research | 1,946 | 38,828 | 40,774 | 40,746 |
Commercialization of Health Research | 1,317 | 26,192 | 27,509 | 27,281 |
National and International Partnerships | 1,442 | 23,728 | 25,170 | 28,083 |
Ethical, Legal and Social Issues | 432 | 2,499 | 2,931 | 6,314 |
Fund health research | . . . . . | . . . . . | . . . . . | 493,549 |
|
|
|
|
|
47,319 | 881,250 | 928,569 | 869,521 | |
|
|
|
|
|
(dollars) | 2008-2009 | 2007-2008 |
Main Estimates | Main Estimates | |
|
|
|
Grants | ||
Grants for research projects and personnel support | 849,370,000 | 798,976,000 |
Canada Graduate Scholarships | 18,880,000 | 10,500,000 |
Institute support grants | 13,000,000 | 13,000,000 |
|
|
|
Total | 881,250,000 | 822,476,000 |
|
|
|
Strategic Outcome
Trade secret exemptions are provided in a way
that balances the right of industry to protect their confidential
business information with the right of workers to receive
accurate information concerning the health and safety hazards
posed by chemicals in the workplace.
Program Activity Descriptions
Claims Exemption Process
Under this activity, the Hazardous Materials Information Review Commission registers claims for exemption received from a supplier or employer who wishes to withhold confidential business information, decides on the validity of the claim, adjudicates and issues decisions on the compliance of the material safety data sheet (MSDS) or label to which the claim relates, and administers an appeal process to these decisions.
Program by Activities | |||
|
|
|
|
(thousands of dollars) | 2008-2009 Main Estimates 2007-2008 | ||
|
|||
Budgetary | Total | Main | |
|
|||
Operating | Estimates | ||
|
|
|
|
Claims Exemption Process | 3,565 | 3,565 | 3,506 |
|
|
|
|
3,565 | 3,565 | 3,506 | |
|
|
|
|
Strategic Outcome
Canadians and their health care system are
protected from excessive pricing for patented medicines sold in
Canada and are informed on pharmaceutical trends.
Program Activity Descriptions
Pharmaceutical trends
Through this program activity, the Patented Medicine Prices Review Board (PMPRB) provides analysis of pharmaceutical price trends and research and development spending by pharmaceutical patentees. It also provides critical analyses of price, utilization and cost trends for prescription drugs, and information on non-patented prescription drug prices. The PMPRB reports on this information and its price review and enforcement activities as they relate to excessive pricing for patented medicines, both annually to Parliament, through the Minister of Health, and through special published studies.
Compliance and enforcement of non-excessive pricing for patented medicines
The PMPRB is responsible for regulating the prices that patentees charge for patented drugs sold in Canada to wholesalers, hospitals, pharmacies or others, for human and veterinary use. Through this program activity, the PMPRB reviews the prices that patentees charge for patented drugs, based on the price review factors in the Patent Act , to ensure that these prices are not excessive. In the event that the Board finds, following a public hearing, that a price is excessive in any market, it may order the patentee to reduce the price and take measures to offset any excess revenues it may have received as a result of excessive prices.
Program by Activities | |||
|
|
|
|
(thousands of dollars) | 2008-2009 Main Estimates 2007-2008 | ||
|
|||
Budgetary | Total | Main | |
|
|||
Operating | Estimates | ||
|
|
|
|
Compliance and enforcement of non-excessive pricing for | |||
patented medicines | 3,194 | 3,194 | . . . . . |
Pharmaceutical trends | 2,648 | 2,648 | . . . . . |
Patented Medicine Prices Review | . . . . . | . . . . . | 11,475 |
|
|
|
|
5,842 | 5,842 | 11,475 | |
|
|
|
|
Strategic Outcome
Healthier Canadians, reduced health disparities, and a stronger public health capacity.
Program Activity
Descriptions
Health Promotion
In collaboration with partners, the Public Health Agency of Canada supports effective actions to promote healthy living, build healthy communities and address the key determinants of health and major risk factors for chronic disease, by contributing to knowledge development, fostering collaboration, and improving information exchange among sectors and across jurisdictions.
Chronic Disease Prevention and Control
Working in cooperation with regional, provincial/territorial, national and international governments and stakeholders (including non-governmental organizations), the program provides national population health assessment and surveillance in relation to chronic diseases. It also provides and supports leadership and expertise in the development and implementation of pan-Canadian chronic disease prevention, control and management strategies. This program is necessary because chronic diseases are among the most common, preventable and costly health problems facing Canadians.
Infectious Disease Prevention and Control
The program promotes improved health for Canadians in the area of infectious diseases through public health actions including surveillance and epidemiology, risk management, public health policy development, and prevention and care programs. This program is necessary as infectious diseases require national attention and national efforts given their current and potential impact on the health of Canadians and the Canadian health care system, and also because new, existing, or re-emerging infectious diseases can pose a serious threat to the health and socio-economic well-being of Canadians.
Emergency Preparedness and Response
The Agency is a national focal point for anticipating, preparing for, responding to and facilitating recovery from public health consequences of natural disasters or human caused emergencies. The program applies the legislative and regulatory provisions of The Quarantine Act . Partnering with Health Canada, other federal departments, the provinces and territories, international organizations and the voluntary sector, the Agency provides leadership in addressing emerging threats through surveillance, risk analysis, and risk management; and implements preparedness priorities. The program manages and supports the development of health-related emergency response plans, including the National Influenza Response Plan. It develops and sponsors emergency preparedness training, and coordinates counter-terrorism preparations for incidents involving hazardous substances. It provides emergency health and social services, and manages the National Emergency Stockpile System.
Strengthen Public Health Capacity
Working with national and international partners, the Agency develops and provides tools, applications, practices, programs and understandings that support and develop the capabilities of front-line public health practitioners across Canada. The Agency facilitates and sustains networks with provinces, territories, and other partners and stakeholders to achieve public health objectives. The Agency's work improves public health practice, increases cross-jurisdictional human resources capacity, contributes to effective knowledge and information systems, and supports a public health law and policy system that evolves in response to changes in public needs and expectations.
Program by Activities
(thousands of dollars) | 2008-2009 Main Estimates | 2007-2008 | ||||
|
|
|
||||
Budgetary | Total | Main | ||||
|
|
|
|
|||
Operating | Grants | Contributions | Less: | Estimates | ||
and other | Revenues | |||||
transfer | credited | |||||
payments | to the vote | |||||
|
|
|
|
|
|
|
Infectious Disease Prevention and Control | 203,480 | 8,595 | 22,843 | . . . . . | 234,918 | . . . . . |
Health Promotion | 70,095 | 11,670 | 121,798 | . . . . . | 203,563 | 186,418 |
Chronic Disease Prevention and Control | 44,769 | 11,795 | 12,396 | . . . . . | 68,960 | 300,469 |
Strengthen Public Health Capacity | 33,600 | 1,094 | 9,426 | . . . . . | 44,120 | 55,600 |
Emergency Preparedness and Response | 39,020 | . . . . . | . . . . . | 50 | 38,970 | 115,855 |
|
|
|
|
|
|
|
390,963 | 33,154 | 166,463 | 50 | 590,530 | 658,342 | |
|
|
|
|
|
|
|
Transfer Payments | ||||||
|
|
|
|
|
|
|
(dollars) | 2008-2009 | 2007-2008 | ||||
Main Estimates | Main Estimates | |||||
|
|
|
|
|
||
Grants | ||||||
Grants to persons and agencies to support health promotion projects in | ||||||
the areas of community health, resource development, training and | ||||||
skill development and research | 22,170,000 | 21,236,000 | ||||
Grants toward the Federal Initiative on HIV/AIDS | 6,565,000 | 8,010,000 | ||||
Grant to the National Cancer Institute of Canada for the Canadian | ||||||
Breast Cancer Research Initiative | 3,000,000 | 3,000,000 | ||||
Grants to graduate students and post-graduate students in public health | ||||||
and university departments in community medicine and public | ||||||
health | 1,094,000 | 1,731,000 | ||||
Grants to individuals and organizations in support of public health | ||||||
infrastructure | 325,000 | 125,000 | ||||
|
|
|
|
|||
Total grants | 33,154,000 | 34,102,000 | ||||
|
|
|
|
|
|
|
Contributions | ||||||
Contributions to non-profit community organizations to support, on a | ||||||
long-term basis, the development and provision of preventative and | ||||||
early intervention services aimed at addressing the health and | ||||||
developmental problems experienced by young children at risk in | ||||||
Canada | 75,088,000 | 75,088,000 | ||||
Contributions to persons and agencies to support health promotion | ||||||
projects in the areas of community health, resource development, | ||||||
training and skill development and research | 44,907,000 | 37,220,000 | ||||
Contributions to incorporated local or regional non-profit Aboriginal | ||||||
organizations and institutions for the purpose of developing early | ||||||
intervention programs for Aboriginal pre-school children and their | ||||||
families | 26,651,000 | 26,651,000 | ||||
Contribution toward the Federal Initiative on HIV/AIDS | 16,439,000 | 12,832,000 | ||||
Contributions to Canadian Blood Services and/or other designated | ||||||
transfusion/transplantation centres to support adverse event | ||||||
surveillance activities | 2,197,000 | 2,197,000 | ||||
Contributions to universities and public health organizations to create | ||||||
public health workforce development products and tools | 1,056,000 | 1,056,000 | ||||
Contributions to individuals and organizations in support of public | ||||||
health infrastructure | 125,000 | 125,000 | ||||
|
|
|||||
Total contributions | 166,463,000 | 155,169,000 | ||||
|
|
|
|
|
|
|
Total | 199,617,000 | 189,271,000 | ||||
|
|
|
|
|
|
|